Predicate Ledger Insights U.S. FDA 510(k) & Recall Record (1976 to 2026)

Post-Market Recall Velocity & Triage · Empirical Regulatory Briefing

FDA 510(k) Predicate Lineage, De-Broadcasted openFDA Recall Velocity, and Post-Market Triage

Reconciling 176,625 U.S. FDA 510(k) clearances, FOICLASS product codes, and 59,705 CDRH and openFDA recall events from accessdata.fda.gov and open.fda.gov strips 19,984,540 synthetic broadcast joins to isolate 48,892 verified recall links across 13,125 K-numbers (7.43%), establishing clean post-market recall velocity baselines while PMA and raw MAUDE reports remain external FDA databases.

Updated: 2026-11-18 Publication ID: 45ee9f8facc7af9d031b Primary Sources: accessdata.fda.gov & open.fda.gov

Reconciling 510(k) Clearances and De-Broadcasted Recall Velocity vs External FDA Databases

Accurate post-market medical device triage requires separating verified regulatory enforcement linkages from noisy administrative joins and distinct external registries. Predicate Ledger deterministically reconciles three authoritative federal bulk datasets: U.S. FDA CDRH 510(k) Premarket Notification clearances (1976 to 2026), FOICLASS three-letter product risk classifications, and deduplicated CDRH and openFDA medical device recall events governed by 21 CFR Part 7 and 21 CFR Part 806. By contrast, separate FDA Premarket Approval (PMA) clinical dossiers, GUDID unique device identifier catalogs, and raw individual adverse event narratives submitted under 21 CFR Part 803 into FDA's Manufacturer and User Facility Device Experience (MAUDE) database remain external FDA databases and are not ingested into Predicate Ledger entity counts.

Understanding that architectural boundary is critical for clinical engineering, pharmacovigilance, and regulatory quality teams. FDA explicitly cautions that raw MAUDE individual adverse event counts cannot be used alone to establish device failure rates because passive reports suffer from duplicate submissions, unverified causality, and missing installed-base denominators. Establishing a clean, de-broadcasted 510(k) clearance and recall-velocity baseline first gives hospital triage teams an audited denominator before they inspect external FDA MAUDE narratives or live manufacturer field correction letters.

Table 1. High-Recall-Density FDA 510(k) Product Cohorts After Broadcast Removal (Minimum 50 Clearances)
Product Code Device Cohort Specialty Cleared 510(k)s Recalled 510(k)s Recalled Device % Cumulative Recalls Class I History
OWB Interventional Fluoroscopic X-Ray System Radiology 325 148 45.54% 639 20
MKJ Automated External Defibrillators (Non-Wearable) Cardiovascular 228 87 38.16% 338 27
NAY System, Surgical, Computer Controlled Instrument Gastroenterology and Urology 167 56 33.53% 248 2
MHX Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) Cardiovascular 431 133 30.86% 298 0
MBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer Orthopedic 146 41 28.08% 103 16
MUJ System, Planning, Radiation Therapy Treatment Radiology 258 71 27.52% 270 0
CHL Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph Clinical Chemistry 188 51 27.13% 192 0
LJT Port & Catheter, Implanted, Subcutaneous, Intravascular General Hospital 288 78 27.08% 143 13

Why Raw openFDA Linkage Inflates Post-Market Recall Velocity by 19.98 Million Rows

Quantitative surveillance teams joining openFDA enforcement endpoints directly against 510(k) clearance tables routinely encounter severe entity-linkage distortion. Whenever an underlying recall notice cites a three-letter FDA product code without enumerating individual K-numbers, openFDA's pre-joined k_numbers array broadcasts that single recall event across every historical 510(k) ever cleared under that product code since 1976.

Deterministic De-Broadcasting Preserves True Cohort Denominators

In Predicate Ledger's reconciliation pipeline (rule version 2026-11-05.1), auditing 40,450 openFDA enforcement records alongside 59,703 CDRH recall records identified and excluded 19,984,540 synthetic broadcast links, while repairing 255 malformed text K-number citations. Without stripping those 19.98 million synthetic joins, naïve recall-velocity models falsely flag nearly every legacy catheter, infusion pump, and imaging platform as recalled, obscuring the verified 13,125 recalled 510(k) clearances (7.43% national baseline) and 48,892 explicit clearance-to-recall links.

Table 2. Predicate Ledger Post-Market Enforcement Reconciliation and De-Broadcasting Audit
Reconciliation Stage Verified Count Post-Market Triage Integrity Role
Deduplicated FDA 510(k) Premarket Clearances (1976 to 2026) 176,625 Canonical clearance denominator across 5 CDRH PMN archives
Implantable / Life-Sustaining 510(k) Clearances 27,147 / 5,737 High-priority triage cohorts derived from FOICLASS flags
Unified CDRH + openFDA Enforcement Recall Events 59,705 Deduplicated across 59,703 recall and 40,450 enforcement rows
Synthetic openFDA Broadcast Links Excluded 19,984,540 Eliminates false-positive product-code recall velocity inflation
Recalls Deterministically Linked to Explicit 510(k) K-Numbers 38,915 Produces 48,892 verified clearance-recall pairs
Distinct Cleared 510(k) Devices With Verified Recall History 13,125 (7.43%) Verified device-level cumulative post-market recall baseline

Post-Market Triage Using Shared 510(k) Predicate Lineage and Recall Velocity

Clinical engineering and quality-assurance teams triaging field correction notices can normalize incoming vendor advisories against Predicate Ledger's de-broadcasted cohort metrics:

  • Separate high-software-iteration cohorts from structural hardware notices: Product codes with elevated Class II update velocity (such as continuous ventilators CBK, anesthesia gas machines BSZ, and infusion pumps FRN) frequently reflect scheduled firmware or cybersecurity patches; a shift toward Class I hardware or sensor notices warrants immediate lot-level biomedical inspection.
  • Distinguish 50-year historical spans from currently open recalls: Cumulative recall counts span 1976 through 2026 across multi-decade product families; always check whether linked recall events are terminated historical actions or currently open field corrections before escalating clinical alerts.
  • Link internal incident tickets to canonical K-numbers and product codes: Recording exact 510(k) K-numbers and three-letter FOICLASS codes in hospital asset inventories accelerates statutory 21 CFR Part 806 quarantine workflows and external FDA database cross-checks.
  • Prioritize implantable and life-sustaining cohorts: Focusing routine surveillance audits on the 27,147 implantable and 5,737 life-sustaining clearances concentrates analyst review where clinical acuity is highest.

Accounting for Classification Lag in openFDA Enforcement Feeds

Practitioners should account for administrative latency between a firm's initial Urgent Medical Device Correction letter under 21 CFR Part 806 and formal FDA hazard classification in weekly openFDA Enforcement Reports. Reviewing historical cohort recall velocity in the Device and Recall Explorer and Predicate Stage provides immediate product-family context while CDRH finalizes Class I or Class II designations.

Methodology and Surveillance Scope Boundaries

Predicate Ledger reconciles cleared 510(k) submissions, FOICLASS classifications, consolidated corporate parent lineages, and de-broadcasted CDRH/openFDA recall events; PMA approvals, GUDID UDI records, and raw MAUDE adverse event reports remain separate external FDA databases. Review full ingestion and quality-gate verification rules on our Methodology page.